Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.515
+0.1502.80%
Volume:693.85K
Turnover:3.85M
Market Cap:4.49B
PE:-23.61
High:5.800
Open:5.395
Low:5.335
Close:5.365
52wk High:9.850
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:3.50
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.234
ROE:-3.45%
ROA:-1.93%
PB:1.06
PE(LYR):-23.61
PS:4.12

Loading ...

ASCLETIS-B Chooses Fixed-Dose Combination of Pioneering Oral Small Molecule GIPR Agonist ASC48 and Oral GLP-1R Agonist ASC30 for Clinical Development

Stock News
·
Jul 15

Mingyu Pharma, Led by Hengrui Veteran, Files for Hong Kong IPO Amid Fierce Market Competition

Deep News
·
Jul 15

ASCLETIS-B (01672) Allocates HK$2.09 Million for Share Buyback on July 14

Stock News
·
Jul 14

Morgan Stanley Adjusts Earnings Per Share Forecasts for SBP GROUP Through 2028, Reiterates 'Overweight' Rating

Stock News
·
Jul 14

Pre-IPO Outlook: With the World's First Fourth-Generation BTK Inhibitor, Can Lupeng Pharmaceutical Unlock a Multi-Billion Dollar Market?

Stock News
·
Jul 13

Warburg Pincus in Advanced Talks for $7B+ Acquisition of Rare Disease Pharma Pantherx with ADIA

Deep News
·
Jul 12

ASCLETIS-B Executes Share Buyback, Spending HK$1.119 Million

Stock News
·
Jul 08

ASCLETIS-B Executes Share Buyback on July 7, Spending HK$1.153 Million

Stock News
·
Jul 07

Fresh Legal Filings Submitted for Investor Claims Against Zitian Tech and Poly Pharm

Deep News
·
Jul 06

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jul 06

Frequent Price Fluctuations and Policy Tailwinds: Is a Pharmaceutical Rally Brewing?

Deep News
·
Jul 06

ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection

Stock News
·
Jul 06

Pharmaceutical Giant Appoints AI Executive to Lead Digital Innovation

Deep News
·
Jul 04

Ocumension Jumps Most in Three Months on China Nod for New Drug Application

Reuters
·
Jul 03

Ocumension Says China NMPA Approves Ot-502 New Drug Application for Postoperative Ocular Inflammation

Reuters
·
Jul 02

Ocumension Therapeutics - Nmpa Approves Ot-502 (dexycu) New Drug Application in China

THOMSON REUTERS
·
Jul 02

Investor Compensation Cases for Changyao Holdings and Poly Pharmaceutical Set for Court Proceedings

Deep News
·
Jul 02

Huiyu Pharmaceutical Inks Strategic Partnership Deal with Avenacy

Stock News
·
Jul 02

Anthropic Launches Internal Drug Discovery Initiative and AI Research Platform, Focusing on Neglected Diseases

Deep News
·
Jul 01

Anthropic Launches Claude Science to Revolutionize Research and Drug Discovery

Stock News
·
Jul 01